Abstract
This report describes a patient who had clinical features of both motor neuron disease and Parkinson's disease. Neuropathological examination and immunocytochemical studies showed that he had motor neuron disease of the progressive muscular atrophy type, and Lewy body Parkinson's disease, with intracytoplasmic inclusion bodies characteristic of both conditions. This is the first detailed description of these two diseases occurring concurrently in the same patient. A review of all previously reported cases of combined motor neuron disease and parkinsonism has led to the following conclusions: (1) that these two neuropathologically defined diseases occur together very infrequently, but (2) that parkinsonism and substantia nigra degeneration are not uncommon as part of the multi-system disease process underlying motor neuron disease.
Similar content being viewed by others
References
Alter M, Schaumann B (1976) Hereditary amyotrophic lateral sclerosis. Eur Neurol 14: 250–265
Bergmann M (1993) Motor neuron disease/amyotrophic lateral sclerosis — lessons from ubiquitin. Pathol Res Pract 189: 902–912
Bergmann M, Kuchelmeister K, Migheli A, Schiffer D, Gullotta F (1993) Motor neuron disease with pallido-luysio-nigral atrophy. Acta Neuropathol 86: 105–108
Biemond A, Beck W (1955) Neural muscle atrophy with degeneration of the substantia nigra. Confin Neurol 15: 142–153
Biemond A, Sinnege J (1955) Tabes of Friedreich with degeneration of the substantia nigra, a special type of hereditary parkinsonism. Confin Neurol 15: 129–142
Bonduelle M, Bouygues P, Delahousse J, Faveret C (1959) Evolution simultanée chez un même malade d'une maladie de Parkinson et d'une sclérose latérale amyotrophique. Rev Neurol (Paris) 101: 63–66
Bonduelle M, Bouygues P, Escourolle R, Lormeau G (1968) Evolution simultanée d'une sclérose latérale amyotrophique, d'un syndrome parkinsonnien et d'une démence progressive. J Neurol Sci 6: 315–332
Boudouresques J, Toga M, Roger J, Khalil R, Vigouroux RA, Pellet W, Hassoun JJ (1967) Etat démentiel, sclérose latérale amyotrophique, syndrome extrapyramidal. Étude anatomique. Discussion nosologique. Rev Neurol (Paris) 116: 693–704
Brait K, Fahn S, Schwarz GA (1973) Sporadic and familial parkinsonism and motor neuron disease. Neurology 23: 990–1002
Brownell B, Oppenheimer DR, Hughes JT (1970) The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 33: 338–357
Burrow JNC, Blumbergs PC (1992) Substantia nigra degeneration in motor neurone disease: a quantitative study. Aust NZ J Med 22: 469–472
Caidas M, Marcutu V, Vuia O (1966) Sclérose latérale amyotrophique associée à la démence et au parkinsonisme. Acta Neurol Psychiatr Belg 66: 719–731
Cordier J (1951) Syndrome parkinsonien avec des amyotrophies rappelant la sclérose latérole amyotrophique et d'origine post-traumatique. Acta Neurol Psychiatr Belg 51: 194–205
Deapen DM, Henderson BE (1986) A case-control study of amyotrophic lateral sclerosis. Am J Epidemiol 123: 790–799
Delisle MB, Gorce P, Hirsch E, Hauw JJ, Rascol A, Bouissou H (1987) Motor neuron disease, parkinsonism and dementia. Acta Neuropathol (Berl) 75: 104–108
Eisen AA, Calne D (1989) Dementia and Parkinson's disease in sporadic amyotrophic lateral sclerosis. Neurology 39 [Suppl I]: 402
Eisen A, Calne D (1992) Amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease: phylogenetic disorders of the human neocortex sharing many characteristics. Can J Neurol Sci 19: 117–123
Gallassi R, Montagna P, Ciardulli C, Lorusso S, Mussuto V, Stracciari A (1985) Cognitive function in motor neuron disease. Acta Neurol Scand 71: 480–484
Gibb WRG, Luthert PJ, Janota I, Lantos PL (1989) Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry 52: 185–192
Gilbert JJ, Kish SJ, Chang L-J, Morito C, Shannak K, Hornykiewicz O (1988) Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates. Ann Neurol 24: 688–691
Gray F, De Baecque C, Sedaru M, Escourolle R (1981) Luysopallido-nigral atrophy and amyotrophic lateral sclerosis. Acta Neuropathol [Suppl VII]: 348–351
Gray F, Eizenbuam JF, Gherardi R, Degos JD, Poirier J (1985) Luyso-pallido-nigral atrophy and amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 66: 78–82
Greenfield JG, Bosanquet FD (1953) The brain stem lesions in parkinsonism. J Neurol Neurosurg Psychiatry 16: 213–226
Greenfield JG, Matthews WB (1954) Post-encephalitic parkinsonism with amyotrophy. J Neurol Neurosurg Psychiatry 17: 50–56
Hasegawa K, Kowa H, Yagishita S (1992) Extrapyramidal system involvement in motor neurone disease. J Neurol Sci 108: 137–148
Hayashi H, Kato S (1989) Total manifestations of amyotrophic lateral sclerosis. J Neurol Sci 93: 19–35
Hirano A, Zimmermann HM (1962) Alzheimer's neurofibrillary changes. Arch Neurol 7: 227–242
Ince P, Irving D, MaCarthur F, Perry R (1991) Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. J Neurol Sci 106: 142–152
Iwasaki Y, Kinoshita M, Ikeda K, Takamiya K, Shiojima T (1990) Cognitive impairment in amyotrophic lateral sclerosis and its relationship to motor disabilities. Acta Neurol Scand 81: 141–143
Iwato M, Hirano A (1979) Current problems in the pathology of amyotrophic lateral sclerosis. Prog Neuropathol 4: 277–298
Kaiya H, Mehraein P (1974) Zur klinik und pathologischen Anatomie des Muskelatrophie-Parkinsonismus-Demenz-Syndroms. Arch Psychiatr Nervenkr 219: 13–27
Kato S, Oda M, Tanabe H (1993) Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 19: 300–304
Kew JJM, Leigh PN, Playford ED, Passingham RE, Goldstein LH, Frackowiak RSJ, Brooks DJ (1993) Cortical function in amyotrophic lateral sclerosis. Brain 116: 655–680
Kew JJM, Goldstein LH, Leigh PN, Abrahams S, Cosgrave N, Passingham RE, Frackowiak RSJ, Brooks DJ (1993) The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. Brain 116: 1399–1423
Kurland LK, Choi NW, Sayre GP (1968) Implications of incidence and geographic patterns on the classification of amyotrophic lateral scleroses. In: Norris F, Kurland L (eds) Motor neurone diseases: research on amyotrophic lateral scleroses and related disorders. Grune & Stratton, New York, pp 38–50
Legrand R, Linquette M, Delahousse J, Gérard A (1959) A propose d'un nouveau cas d'association d'une maladie de Parkinson et d'une sclérose latérale amyotrophique. Rev Neurol (Paris) 101: 191–193
Leigh PN, Whitwell H, Garofalo O, Buller J, Swash M, Martin JE, Gallo J-M, Weller RO, Anderton BH (1991) Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Brain 114: 775–788
Lowe J (1994) New pathological findings in amyotrophic lateral sclerosis. J Neurol Sci 123 [Suppl]: 38–51
Lowe J, Lennox G, Jefferson D, Morrell K, McQuire D, Gray T, Landon M, Doherty FJ, Mayer RJ (1988) A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin Neurosci Lett 94: 203–210
Lowe J, McDermott H, Landon M, Mayer RJ, Wilkinson KD (1990) Ubiquitin carboxyl-terminal hydroxylase (PGP9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 161: 153–160
Lowe J, McDermott H, Pike I, Spendlove I, Landon M, Mayer R (1992) B-crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J Pathol 166: 61–68
Lowe J, Mayer RJ, Landon M (1993) Ubiquitin in neurodegenerative diseases. Brain Pathol 3: 55–65
Ludolph AC, Langen KJ, Regard M, Herzog H, Kemper B, Kuwert T, Bottger IG, Feinendegen L (1992) Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand 85: 81–89
Mizutani T, Sakamaki S, Tsuchiya N, Kamei S, Kohzu H, Ida M, Shiozawa R, Takasu T (1992) Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators. Acta Neuropathol 84: 372–377
Patrikios MJ (1951) Sclérose latérale amyotrophique avec mouvement involuntaire des doigts et du poignet gauches de caractère extrapyramidal. Rev Neurol (Paris) 85: 60–62
Perry RH, Irving D, Tomlinson BE (1990) Lewy body prevalence in the ageing brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology, and catacholaminergic nuclei. J Neurol Sci 100: 223–233
Pilz P, Budka H, Lassmann H (1988) Diffuse Lewy body disease masquerading as motor neuron disease: a generalised disorder of the neuronal cytoskeleton. Clin Neuropathol 7: 198
Sasaki S, Tsutsumi Y, Yamane K, Sakuma H, Maruyama S (1992) Sporadic amyotrophic lateral sclerosis with extensive neurological involvement. Acta Neuropathol 84: 211–215
Schmitt HP, Emser W, Heimes C (1984) Family occurrence of amyotrophic lateral sclerosis, parkinsonism, and dementia. Ann Neurol 16: 642–648
Sercl M, Kovarik J (1963) On the familial incidence of amyotrophic lateral sclerosis. Acta Neurol Scand 39: 169–176
Serratrice GT, Toga M, Pellissier JF (1983) Chronic spinal muscular atrophy and pallidonigral degeneration: report of a case. Neurology 33: 306–310
Subramaniam JJ, Yiannikas C (1990) Multimodality evoked potentials in motor neuron disease. Arch Neurol 47: 989–994
Takahashi H, Oyanagi K, Ikuta A, Tanaka M, Yuasa T, Miyatake T (1993) Widespread multiple system degeneration in a patient with familial amyotrophic lateral sclerosis. J Neurol Sci 120: 15–21
Takahashi H, Snow BJ, Bhatt MH, Peppard R, Eisen A, Calne DB (1993) Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet 342: 1016–1018
Tanaka J, Nakamura H, Tabuchi Y, Takahashi K (1984) Familial amyotrophic lateral sclerosis: features of multisystem degeneration. Acta Neuropathol (Berl) 64: 22–29
Tranchant C, Dugay M-H, Mohr M, Wasser P, Warter J-M (1992) Familial motor neuron disease with Lewy body-like inclusions in the substantia nigra, the subthalamic nucleus, and globus pallidus. J Neurol Sci 108: 18–23
Tsujiyama Y, Shigeta M, Kudo M, Takayama K (1967) Ein Fall von atypischer Pickscher Krankheit. Brain Nerve 19: 927–931
Van Bogaert L, Radermeker MA (1954) XXII. Scléroses latérales amyotrophique typiques et paralysis agitantes héréditaires, dans une même famille, avec une forme de passage possible les deux affections. Monatsschr Psychiatr Neurol 127: 185–203
Wechsler IS, Davison C (1932) Amyotrophic lateral sclerosis with mental symptoms. A clinicopathological study. Arch Neurol Psychiatry 27: 859–880
Wolf HK, Crain BJ, Siddique T (1991) Degeneration of the substantia nigra in familial amyotrophic lateral sclerosis. Clin Neuropathol 10: 291–296
Yagishita S, Itoh H, Amano N, Nakano T (1980) Atypical senile dementia with widespread Lewy type inclusions in the cerebral cortex. Acta Neuropathol (Berl) 49: 211–212
Yoshimura M (1983) Cortical changes in the parkinsonian brain: a contribution to the delineation of ‘diffuse Lewy body disease’. J Neurol 229: 17–32
Yvonneau M, Vital C, Belly C, Coquet M (1971) Syndrome familial de sclérose latérale amyotrophique avec démence. Encéphale 6: 449–462
Ziegler DK, Schimke RN, Kepes JJ, Rose DL, Klinkerfuss G (1972) Late onset ataxia, rigidity, and peripheral neuropathy. Arch Neurol 27: 52–66
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Williams, T.L., Shaw, P.J., Lowe, J. et al. Parkinsonism in motor neuron disease: case report and literature review. Acta Neuropathol 89, 275–283 (1995). https://doi.org/10.1007/BF00309344
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00309344